ABCB1 and breast carcinoma: Over-activated STAT3 has been found in a large number of drug-sensitive and drug-resistant breast cancers, and STAT3 inhibition may be a viable treatment option for both drug-sensitive and drug-resistant breast cancers by regulating STAT3 target genes and inhibiting STAT3-mediated MDR1 gene expression2.